NASDAQ:RPRX | Profit Breakdown | Royalty Pharma plc

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2018-12-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30$674.14M$133.12M$81.49M$17.88M
2026-03-31$630.58M$563.04M$468.26M$294.69M
2025-12-31$621.99M$388.38M$355.91M$214.21M
2025-09-30$609.29M$427.16M$444.21M$288.22M
2025-06-30$578.67M$209.8M$92.64M$32.18M
2025-03-31$568.25M$534.18M$434.43M$239.35M
2024-12-31$593.64M$361.51M$334.35M$208.21M
2024-09-30$564.69M$735.07M$806.36M$543.99M
2024-06-30$537.27M$269.63M$194.38M$102M
2024-03-31$567.98M-$73.77M-$4.27M$4.78M
2023-12-31$596.07M$612.9M$717.59M$494.34M
2023-09-30$536.31M$151.44M$122.08M$72.11M
2023-06-30$538.2M$248.84M$351.34M$227.63M
2023-03-31$683.97M$478.97M$509.09M$340.76M
2022-12-31$565.75M-$482.66M-$610.03M-$456.08M
2022-09-30$573.46M$192.21M$220.41M$142.65M
2022-06-30$535.96M$377.79M$491.6M$304.5M
2022-03-31$562.05M$219.72M$128.08M$51.76M
2021-12-31$575.7M$153.42M$53.67M$7.9M
2021-09-30$585.77M$303.05M$221.8M$101.93M
2021-06-30$554.96M$744.95M$806.76M$440.78M
2021-03-31$573.03M$229.3M$158.98M$69.12M
2020-12-31$572.14M$314.06M$366.63M$171.09M
2020-09-30$538.4M$510.57M$624.25M$290.63M
2020-06-30$510.93M$409.35M$601.98M$442.07M
2020-06-17$515.79M
2020-03-31$500.88M$361.43M$109.1M$71.24M
2019-12-31$457.49M$1.33B$1.45B$1.42B
2019-09-30$464.28M$532.5M$440.03M$408.98M
2019-06-30$457.61M$327.86M$178.77M$151.71M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31$2.38B$1.56B$1.32B$770.95M
2024-12-31$2.26B$1.29B$1.33B$858.98M
2023-12-31$2.35B$1.49B$1.7B$1.13B
2022-12-31$2.24B$307.07M$230.06M$42.83M
2021-12-31$2.29B$1.43B$1.24B$619.73M
2020-12-31$2.12B$1.6B$1.7B$975.04M
2019-12-31$1.81B$2.62B$2.46B$2.35B
2018-12-31$1.79B$1.36B$1.52B$1.38B